<?xml version="1.0" encoding="UTF-8"?>
<ref id="B140" class="ref">
 <label class="label">139</label>
 <element-citation publication-type="journal" class="element-citation">
  <person-group person-group-type="author" class="person-group">
   <name class="name">
    <surname class="surname">Mu</surname>
    <given-names class="given-names">G.-G.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Zhang</surname>
    <given-names class="given-names">L.-L.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Li</surname>
    <given-names class="given-names">H.-Y.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Liao</surname>
    <given-names class="given-names">Y.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Yu</surname>
    <given-names class="given-names">H.-G.</given-names>
   </name>
  </person-group>
  <article-title class="article-title">Thymoquinone pretreatment overcomes the insensitivity and potentiates the antitumor effect of gemcitabine through abrogation of notch1, PI3K/Akt/mTOR regulated signaling pathways in pancreatic cancer</article-title>
  <source class="source">
   <italic toggle="yes" class="italic">Digestive Diseases and Sciences</italic>
  </source>
  <year class="year">2015</year>
  <volume class="volume">60</volume>
  <issue class="issue">4</issue>
  <fpage class="fpage">1067</fpage>
  <lpage class="lpage">1080</lpage>
  <pub-id pub-id-type="doi" class="pub-id">10.1007/s10620-014-3394-x</pub-id>
  <pub-id pub-id-type="other" class="pub-id">2-s2.0-84934292263</pub-id>
  <pub-id pub-id-type="pmid" class="pub-id">25344906</pub-id>
 </element-citation>
</ref>
